InvestorsHub Logo
Followers 155
Posts 2641
Boards Moderated 0
Alias Born 01/29/2004

Re: LBSR TO DA MOON post# 437195

Thursday, 10/26/2023 5:02:25 PM

Thursday, October 26, 2023 5:02:25 PM

Post# of 462062
Thanks for posting. The totality of results.

FWIW - Here is the latest update from MayoMobile: ...


For What It's Worth (FWIW)?

Well, read Mayo's posting word by word, point by point. Obviously, he's acquired and scrutinized the entire paper, which, for me, was pay-walled. I was able to read only the abstract and article summary that got posted. Simply, Anavex 3-71 has phenomenal treatment and prophylactic powers against Alzheimer's disease.

Yes, like many others, I've focused primarily on blarcamesine's and Anavex 3-71's activation of the sigma-1 receptor protein. By itself, sigma-1 receptor activation is profound; will revolutionize CNS (and other) disease therapeutics. But, intelligently, from the entire paper, Mayo expands into Anavex 3-71's M1 activation and the wide diversity of other pathologies being thereby resolved by the drug.

Altogether, simply phenomenal. Too good to believe. But the study's data validate its findings.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News